Annual Reports

Browse

Browsing Annual Reports by Issue Date

Filter results by year or month
Now showing 1 - 20 of 28
  • Thumbnail Image
    Item
    ANSTO annual report 1999-00.
    (Australian Nuclear Science and Technology Organisation, 2000)
    The period from July 1999 to June 2000 has, yet again, been both exciting and challenging. Our most important project is the Replacement Research Reactor Project - important not only for the future of the Organisation but also for the maintenance and development of a range of scientific and technological expertise that will underpin Australia's socio-economic development in the knowledge era. In August 1999 this project received unanimous approval from the bipartisan Public Works Committee. ANSTO immediately released the Request for Tender to the four prequalified vendors. All vendors, in alliance or partnership with Australian engineering companies, submitted proposals on the closing date of January 3rd, 2000. These proposals were reviewed and evaluated by internal and external experts, culminating in the final recommendation that INVAP SE, in alliance with John Holland Construction and Engineering Pty Ltd and Evans Deakin Industries Limited, be awarded the contract for the detailed engineering design, construction and commissioning of the replacement research reactor at the Lucas Heights Science and Technology Centre. After obtaining all relevant approvals, the contract was signed early in July and marked by a ceremony involving many of the people who had contributed to the process. The tender selection process was audited from start to finish and the relevant audit and review reports posted on ANSTO's website as part of our community advice. As this Annual Report goes to press the project is well underway. ANSTO staff are to be commended for their professionalism and dedication throughout the replacement research reactor project to date. They have worked tirelessly and met all major milestones under their control. It was heartening to learn that our comprehensive and independently audited consultation program during the environmental assessment phase of the replacement research reactor project was acclaimed by two awards from the Public Relations Institute of Australia. All of us at ANSTO appreciate the very considerable support and encouragement we have received from government, individuals, companies and professional societies across the science, engineering, medical and policy spectra. We look forward to working with our stakeholders to ensure that the scientific instruments developed for the various beamlines on the reactor are capable of delivering world class outcomes. During the past year current ANSTO's core nuclear facilities have been in strong demand. Staff and students from universities across Australia have accessed the facilities through AINSE, there being around 160 AINSE-supported university projects in the past year. ANSTO staff not only facilitate the execution of these projects but also undertake research to underpin other important elements of ANSTO's mission. Such projects are frequently carried out in collaboration with national and international teaming partners.
  • Thumbnail Image
    Item
    ANSTO annual report 2000-01
    (Australian Nuclear Science and Technology Organisation, 2001) The Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation. It has a staff of approximately 800 and is located at the Lucas Heights Science and Technology Centre, some 40 km south west of Sydney city centre. The science and technology centre occupies 70 hectares and is surrounded by a 1.6 km buffer zone. ANSTO operates Australia’s only nuclear reactor, the research reactor HIFAR (which stands for High Flux Australian Reactor). The reactor is used to produce radioactive products for use in medicine and industry. It is also used extensively as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. The organisation also operates the National Medical Cyclotron, an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. The facility is located in the grounds of the Royal Prince Alfred Hospital in Camperdown, an inner west suburb of Sydney. ANSTO provides the broad range of technical expertise needed to support Australia’s nuclear interests. It advises the Commonwealth Government on issues associated with the nuclear fuel cycle and the operation of nuclear facilities and it supports industry through the development and application of nuclear science based technology and associated capabilities. ANSTO organises its activities under six core business areas. Safety and environmental protection arrangements at ANSTO facilities are reported against separately. Further information about the organisation is available on ANSTO’s web site at www.ansto.gov.au.
  • Thumbnail Image
    Item
    ANSTO annual report 2001-02
    (Australian Nuclear Science and Technology Organisation, 2002) Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and the centre of Australian nuclear expertise. ANSTO is responsible for delivering specialised advice, scientific services and products to government, industry, academia and other research organisations. It does so through the development of new knowledge, delivery of quality services and support for business opportunities. ANSTO’s nuclear infrastructure includes the research reactor HIFAR (High Flux Australian Reactor), particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. HIFAR is Australia’s only nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. The organisation also operates the National Medical Cyclotron, an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. This is located in the grounds of the Royal Prince Alfred Hospital in Camperdown, close to Sydney’s central business district. ANSTO has a salaried staff of approximately 850. Its main site is located at the Lucas Heights Science and Technology Centre (LHSTC), 40 km south west of Sydney’s central business district. The LHSTC occupies 70 hectares and is surrounded by a 1.6 km buffer zone. ANSTO’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 and translated into action through corporate drivers of vision, mission and strategic goals.
  • Thumbnail Image
    Item
    ANSTO annual report 2002-03
    (Australian Nuclear Science and Technology Organisation, 2003) Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development (R&D) organisation and the centre of Australian nuclear expertise. With a salaried staff of approximately 830, ANSTO is responsible for delivering specialised advice, scientific services and products to government, industry, academia and other research organisations. We do so through the development of new knowledge, delivery of quality services and support for business opportunities. ANSTO’s nuclear infrastructure includes the research reactor HIFAR (High Flux Australian Reactor), particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. HIFAR is Australia’s only nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. ANSTO also operates the National Medical Cyclotron (NMC), an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. It is located in the grounds of the Royal Prince Alfred Hospital in Camperdown. Located at the Lucas Heights Science and Technology Centre (LHSTC), 40 km south west of Sydney’s central business district, ANSTO’s main site occupies 70 hectares, surrounded by a 1.6 km buffer zone. ANSTO’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 and translated into action through corporate drivers of vision, mission and strategic goals.
  • Thumbnail Image
    Item
    ANSTO annual report 2003-04
    (Australian Nuclear Science and Technology Organisation, 2004)
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and the centre of Australian nuclear expertise. With a salaried staff of approximately 830, ANSTO is responsible for delivering specialised advice, scientific services and products to government, industry, academia and other research organisations. We do so through the development of new knowledge, delivery of quality services and support for business opportunities. ANSTO’s nuclear infrastructure includes the research reactor, HIFAR (High Flux Australian Reactor), particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. HIFAR is Australia’s only nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. ANSTO also operates the National Medical Cyclotron, an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. It is located in the grounds of the Royal Prince Alfred Hospital in Camperdown. Located at the Lucas Heights Science and Technology Centre (LHSTC), 40 km south west of Sydney’s central business district, ANSTO’s main site occupies 70 hectares, surrounded by a 1.6 km buffer zone. ANSTO’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 and translated into action through corporate drivers of vision, mission and strategic goals.
  • Thumbnail Image
    Item
    Corporate social responsibility report 2005-05
    (2005) Australian Nuclear Science and Technology Organisation; Australian Nuclear Science and Technology Organisation
    Welcome to ANSTO’s second corporate social responsibility (CSR) report. We are firmly committed to reporting on our activities in environmental and social terms, as well as financially. In doing so we aim to be open about issues as well as help the Australian community better understand the benefits of our work.
  • Thumbnail Image
    Item
    ANSTO annual report 2004-05
    (Australian Nuclear Science and Technology Organisation, 2005) The Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and the centre of Australian nuclear expertise. With approximately 860 staff, ANSTO is responsible for delivering specialised advice, scientific services and products to government, industry, academia and other research organisations. We do so through the development of new knowledge, the delivery of quality services and the provision of support for business opportunities. ANSTO’s nuclear infrastructure includes the research reactor HIFAR (High Flux Australian Reactor), particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. HIFAR is Australia’s only nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. A replacement for HIFAR, OPAL – the Open Pool Australian Light-water reactor – is in its final stages of construction. ANSTO also operates the National Medical Cyclotron, an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. It is located in the grounds of the Royal Prince Alfred Hospital in Camperdown. ANSTO also manages access to overseas synchrotron facilities for Australian scientists. ANSTO’s main site is located 40 km south west of Sydney’s central business district, occupies 70 hectares and is surrounded by a 1.6 km buffer zone. ANSTO’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 and is translated into action through corporate drivers of vision, mission and strategic goals.
  • Thumbnail Image
    Item
    Corporate social responsibility report 2003-04
    (Australian Nuclear Science and Technology Organisation, 2005) The Australian Nuclear Science and Technology Organisation
    This report reflects our desire to share and communicate with our various stakeholders; whether they support the work we do or are opposed to it. There are a number of mechanisms through which we invite people to interact with us, and we welcome continuing discussion on a range of issues relevant to our operations. As many already know, ANSTO operates at the leading edge of nuclear medicine, helping thousands of Australians enjoy healthier lives every year. Australians have benefited from our work in assisting the aerospace, agriculture, manufacturing, mining, minerals, food and oil exploration sectors. Our work in developing techniques to investigate climate change, salinity and groundwater pollution has also added greatly to the understanding and advancement of environmental research in these areas. What is important to us is our insistence to deliver these medical, industrial and scientific benefits through safe and secure operational management. Indeed, the excellent safety record of our High Flux Australian Reactor (HIFAR) has been maintained over the 47 years of its operation and we are vigilant in our compliance with the license regulations required by the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) for our facilities and radioactive sources. The challenge for us is to find ways to ensure we continue to deliver these services and responsibilities openly and transparently without compromising classifications, regulations or confidentialities. We are not claiming to be perfect but we desire the opportunity to illustrate, identify and explore those aspects of our work that we do well, along with those that require further improvement. While many significant achievements occurred during 2003-04, one of the most noteworthy was our obtaining ISO 14001 certification - the world’s highest possible environmental performance standard. Nuclear science by its very nature means we must be extremely precise in our handling and production of radiopharmaceuticals and radioisotopes. With ISO 14001, we now accept the responsibility to ensure that we take the same duty of care with our day-to-day use of everything from drinking water to the quantity of paper used and the energy we consume. What will become apparent as you read this report is that ISO 14001 instils a sense of duty and ownership among every employee to find ways to work smarter, more safely and securely and in ways that leave the smallest footprint possible on the environment. The year ahead presents a new set of challenges and activities, including preparing to say goodbye to the HIFAR, which has served the organisation so well over the past half-century, and to the commissioning of OPAL, the Open Pool Australian Light-water reactor. OPAL will be a state-of-the art nuclear facility that will give us even greater capabilities in developing nuclear medicines and other products. For now, though, we invite you to join us in our first attempt at a consolidated assessment of the core values, strategies and policies across every sphere of our activities, ranging from community and workplace relations to environmental, health and safety practices. We seek to share with you our successes and identify those areas of operation that require further review and refinement. Our objective in this journey is not only to interact with staff, customers and stakeholders, but with our neighbours, who figure greatly in our continued success.
  • Thumbnail Image
    Item
    Corporate social responsibility report 2004-05
    (Australian Nuclear Science and Technology Organisation, 2005) The Australian Nuclear Science and Technology Organisation
    The essence of this report is showing how we constantly examine all aspects of our multi-faceted operation: to foster successful innovation, identify emerging problems and pursue opportunities for improvement. We learn from those who know us best – our employees, customers, suppliers, research collaborators, business partners and community groups. In addition, we participate in extensive and exhaustive external reviews of our activities. These are conducted by a number of expert regulatory organisations and environmental, quality and financial auditors, as well as in our reporting to the Australian Government. The preparation for commissioning of our new OPAL (Open Pool Australian Light-water) reactor has brought particular public and regulator attention to our work over the last year, and this is set to continue. We also engaged in extensive consultation in the development of our Strategic Directions for the coming five years. As well as setting four Strategic Directions – focusing on research excellence, issues of national importance, our expertise and facilities and our external relationships – we set a new vision, mission and core values. CSR principles are woven throughout our Strategic Directions: in what we do, where we aim to be, and how we will get there. For example, our Strategic Directions give particular emphasis to nuclear medicine. Our mission includes a new element devoted to this core aspect of our work, which benefits hundreds of thousands of patients each year. In our first Strategic Direction we identify excellence as a crucial element of success. We are using our expertise, facilities and intellectual property to help solve critical social, environmental and economic problems in areas such as climate change, water management and cancer. To maximise the reach of our work and minimise duplication, we collaborate with other leading public and private sector organisations in the quest to develop new knowledge, products and services. An example of this is collaboration we have undertaken with government and international agencies, that is key to our counter-terrorism research and services, which are part of the issues of national importance on which we focus in our second Strategic Direction. As Australia’s centre of nuclear expertise and one of this country’s premier scientific facilities, we know expectations of us are high. This report aims to show how we are meeting our stakeholders’ expectations (and where we are not yet up to the mark, what we are doing to change). This effort does not just involve everyone within the organisation – it also requires that we and our key stakeholders work together in a spirit of openness and commitment for the benefit of the entire Australian community.
  • Thumbnail Image
    Item
    ANSTO annual report 2005-06
    (Australian Nuclear Science and Technology Organisation, 2006) The Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and the centre of Australian nuclear expertise. With approximately 860 staff, ANSTO is responsible for delivering specialised advice, scientific services and products to government, industry, academia and other research organisations. We do so through the development of new knowledge, the delivery of quality services and the provision of support for business opportunities. ANSTO’s nuclear infrastructure includes the research reactor HIFAR (High Flux Australian Reactor), particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. HIFAR is Australia’s only nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. A replacement for HIFAR, OPAL – the Open Pool Australian Light-water reactor – is in its commissioning phase. ANSTO also operates the National Medical Cyclotron, an accelerator facility used to produce certain short-lived radioisotopes for nuclear medicine procedures. ANSTO also manages access to overseas synchrotron facilities for Australian scientists. ANSTO’s main site is located 40 km south west of Sydney’s central business district, occupies 70 hectares and is surrounded by a 1.6 km buffer zone. ANSTO’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 (ANSTO Act) and is translated into action through corporate drivers of vision, mission and strategic goals.
  • Thumbnail Image
    Item
    Corporate social responsibility report 2005-06
    (Australian Nuclear Science and Technology Organisation, 2006) Australian Nuclear Science and Technology Organisation
    What were the highlights of ANSTO’s CSR performance this year? Our increased community interaction was a definite highlight, in terms of reaching out to schools and communities. Important confirmation of the desire for ANSTO’s CSR reporting came with our market research results. We have used this information to modify report content including our CSR commitments, and will continue to seek feedback to better meet stakeholder expectations (our CSR commitments are also now more in line with organisational Strategic Directions). Increased emphasis of safety on site was another highlight. We have decreased the severity of incidents, and in April to June cut our time lost through injury frequency rate by over 50 per cent. A good result, but we can still do better. Construction of a new $1.3 million specially designed site entrance also shows our commitment to staff road safety. What were the social and economic benefits of ANSTO’s scientific research this year? Our sewage recycling ‘bioreactor’ is an invention with high potential for very good environmental outcomes. We have interest from major municipal authorities to trial the technology, with potential savings of tens of millions of dollars. We continue to support local industry with provision of expert services, such as software for the better management of pipeline strength testing and stress analysis for power generation plants. ANSTO research is contributing to our understanding of what is happening with our water, by tracing water flows and understanding salinity. These are major issues which help us understand climate change. Our CeramiSphere technology has the demonstrated ability to make narcotic drugs tamper-proof. We are in negotiation with a major pharmaceutical company to ensure important pain relief drugs are not diverted for illegal use. This approach of ‘spinning-off’ our technology allows ANSTO to adapt its core research into platforms that Australian industry can use to solve specific issues. What role will nuclear science and technology play in Australian science and industry in coming years? There is great excitement in the Australian scientific community. OPAL’s neutron scattering† will ensure this is a key technology for the next decade. It will impact on molecular biology, health and food science research. ANSTO will also play an important role in advising government and community about the benefits of nuclear science and technology, and allowing the nuclear power debate to proceed on the basis of reliable information. What will OPAL do for Australia? As a world-class facility, OPAL will irradiate silicon for semi-conductors, secure radioisotope supplies for nuclear medicine and provide neutrons for research. For example, our food science project uses OPAL’s capacities and is an exciting opportunity to understand more about food. Our neutron scattering facility will help keep scientists in Australia, and attract some back. How is ANSTO working towards nuclear safety and security in our region? We have a long and well earned reputation as a source of advice and expertise for countries in the region. ANSTO leads a major project promoting safety culture in nuclear facilities, with nine regional countries involved. We actively assist regional countries to secure vulnerable radioactive sources, which are a potential danger with the realities of terrorism very much upon us.
  • Thumbnail Image
    Item
    ANSTO annual report 2006-07
    (Australian Nuclear Science and Technology Organisation, 2007) The Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and the centre of Australian nuclear expertise. With approximately 950 staff, ANSTO is responsible for delivering specialised advice, scientific services and products togovernment, industry, academia and other research organisations. We do so through the development of new knowledge, the delivery of quality services and the provision of support for business opportunities. ANSTO’s nuclear infrastructure includes the Open Pool Australian Light-water reactor (OPAL), Australia’s new $470 million research reactor, particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. OPAL is Australia’s only operating nuclear reactor. It is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. The High Flux Australian Reactor (HIFAR), which was Australia’s first reactor, was officially shut down in January 2007 and is currently awaiting decommissioning. ANSTO also operates the National Medical Cyclotron, an accelerator facility used to produce short-lived radioisotopes for nuclear medicine procedures. ANSTO also manages access to overseas synchrotron facilities for Australian scientists. ANSTO’s main site is located 40 km south west of Sydney’s central business district, occupies 70 hectares and is surrounded by a 1.6 km buffer zone. The Organisation’s general purpose is prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 (ANSTO Act) and is translated into action through corporate drivers of vision, mission and strategic goals.
  • Thumbnail Image
    Item
    ANSTO annual report 2007-08
    (Australian Nuclear Science and Technology Organisation, 2008) Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is Australia’s national nuclear research and development organisation and is the centre of Australian nuclear expertise. ANSTO operates Australia’s nuclear research reactor OPAL. OPAL is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. ANSTO’s nuclear infrastructure also includes particle accelerators, radiopharmaceutical production facilities, and a range of other unique research facilities. ANSTO’s main site is located 40 kilometres south west of Sydney’s central business district, occupies 70 hectares and is surrounded by a 1.6 kilometre buffer zone. ANSTO also operates the National Medical Cyclotron, an accelerator facility used to produce short-lived radioisotopes for nuclear medicine procedures. The cyclotron is situated at the Royal Prince Alfred Hospital in Camperdown, Sydney. The organisation’s functions are prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 (ANSTO Act) and are translated into action through corporate drivers of vision, mission and strategic goals.
  • Thumbnail Image
    Item
    Research selections 2009
    (Australian Nuclear Science and Technology Organisation, 2009) Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is the home of Australia’s nuclear science expertise. This unique expertise is applied to radiopharmaceutical production and research, climate change research, water resource management, materials engineering, neutron scattering and a range of other scientific research disciplines. ANSTO is a Federal Government agency and operates Australia’s only nuclear reactor OPAL – used for research and isotope production. ANSTO applies nuclear science in a wide range of areas for the benefit of all Australians. Accelerators are used to analyse materials – often using extremely small samples – to determine their elemental composition and age. ANSTO currently has two accelerators, ANTARES and STAR, both of which are used in ion beam analysis and accelerator mass spectrometry. Over the next four years, ANSTO will be establishing a Centre for Accelerator Science including adding two new accelerators, putting ANSTO at the forefront of this field worldwide. The new accelerators are a low energy multi-isotope accelerator mass spectrometer and a new medium-energy tandem accelerator. ANSTO has also become a partner in a national accelerator collaboration – Australian Collaboration for Accelerator Science (ACAS) – aimed at maintaining state-of-the-art accelerator-based facilities and a world-class pool of accelerator scientists in Australia.
  • Thumbnail Image
    Item
    ANSTO annual report 2008-09
    (Australian Nuclear Science and Technology Organisation, 2009) Australian Nuclear Science and Technology Organisation
    ANSTO is Australia’s national nuclear research and development organisation and is the centre of Australian nuclear expertise. It is part of the Australian Government portfolio of Innovation, Industry, Science and Research. ANSTO undertakes research in the applications of nuclear science and technology and delivers specialised advice, scientific services and products to government, universities, other research organisations, international organisations and businesses in areas as diverse as mining and radiopharmaceuticals. About one-third of ANSTO’s staff are involved in research. The balance are in business services, operations and support to government roles. ANSTO operates Australia’s nuclear research reactor OPAL which is used to produce radioactive products for use in medicine and industry, as a source of neutron beams for scientific research and to irradiate silicon for semiconductor applications. ANSTO’s research infrastructure also includes accelerators, cyclotrons and associated instruments as well as workshops, pilot plants and specialist laboratories. ANSTO’s research infrastructure is used extensively by other members of the Australian and international research communities including researchers from universities, other science and technology organisations and industry. ANSTO also manages the Access to Major Research Facilities Program (AMRFP), which provides Australian researchers with access to major international facilities. ANSTO’s main campus is located 40 km south west of Sydney’s central business district, occupies 70 hectares and is surrounded by a 1.6 km buffer zone. The organisation’s functions are prescribed by the Australian Nuclear Science and Technology Organisation Act 1987 (ANSTO Act) and are translated into action through its strategic and annual planning process.
  • Thumbnail Image
    Item
    2010-2015 corporate plan
    (Australian Nuclear Science and Technology Organisation, 2010-09-01) Australian Nuclear Science and Technology Organisation
    Nuclear science and technology is a dynamic area of endeavour that focuses on the basic building blocks of matter at the atomic and sub-atomic level. It has many uses, including helping to gain a better understanding of both biological and physically complex systems, and in improving our quality of life. Nuclear science and technology’s potential to improve our lives and unlock the many mysteries of science is well established, but new and exciting areas are still open for innovation. This document details ANSTO’s Corporate Plan (the Plan) for the period 2010-2015, in particular: Our vision, purpose and core values A contextual overview of nuclear science and technology Findings from strategic and operational reviews undertaken over the past two years Strategic priorities for 2010-2015 How we will measure our success in implementing the Plan. Key external documents that have informed development of the Plan include: Statement of Expectations for the Australian Nuclear Science and Technology Organisation (Minister for Innovation, Industry, Science and Research) Australia’s National Research Priorities Powering Ideas: An Innovation Agenda for the 21st Century National Security Science and Innovation Strategy Inspiring Australia: A National Strategy for Engagement with the Sciences Australian Nuclear Science and Technology Organisation Act 1987. Internal documents include ANSTO’s: 2030 Scenario Planning Research Papers (2010) 2055 Infrastructure Plan (2010) ANSTO Statement of Intent (2010).
  • Thumbnail Image
    Item
    ANSTO annual report 2009-10
    (Australian Nuclear Science and Technology Organisation, 2010-10) Australian Nuclear Science and Technology Organisation
    ANSTO is Australia’s national nuclear science and technology organisation and represents a concentration of Australia’s best nuclear science capabilities. It is part of the Australian Government portfolio of Innovation, Industry, Science and Research. ANSTO provides policy advice to the Australian Government in relation to all matters within the ambit of nuclear science and technology. In addition, ANSTO maintains critical capabilities to support government in undertaking its regional and international role and obligations in relation to nuclear science and technology. Research and innovation are central to ANSTO’s mission and mandate. Key outcomes include: research publications; the securing of intellectual property; training of research students; software development; engineering designs and demonstrators and engineering services; pilot plants and industrial consultancy for clients. We also license technology that arises from our innovation activities. ANSTO provides local and global partners with access to its research and innovation infrastructure to leverage their own research and innovation activities. This collaboration considerably expands the opportunity for the development of locally and globally significant research that will benefit all. ANSTO manufactures products and provides specialised services for customers. These commercial activities draw on ANSTO’s scientists and engineers to develop new products and manufacturing approaches and enhance product quality. Our businesses are focussed on the health of Australians, particularly in the application of radioisotopes for imaging and therapy; the application of mineral processing for naturally occurring radioactive materials; safe treatment and disposition of nuclear waste; and specialised irradiation services. ANSTO is the custodian of landmark infrastructure deployed in the national interest. ANSTO operates Australia’s OPAL multipurpose research reactor. Research reactors are essentially ‘neutron factories’. The neutrons are used for scientific research, the production of radioisotopes used in medicine, activating targets (such as mineral samples for research) and modifying the conductivity of single crystal silicon used for microelectonics. Complementing the OPAL reactor are particle accelerators which are part of the essential toolkit used for precisely dating geological samples, studying the history of climate variability, and materials research, among other applications. ANSTO is a leader in pilot plant design, operation and management for the mining industry. These plants are a significant factor in transferring laboratory results to industry and providing industry with greater confidence prior to full-scale plant development.
  • Thumbnail Image
    Item
    Research selections 2011
    (Australian Nuclear Science and Technology Organisation, 2011-10) Australian Nuclear Science and Technology Organisation
    The Australian Nuclear Science and Technology Organisation (ANSTO) is the home of Australia’s nuclear science expertise. This expertise is applied to radiopharmaceutical production and biomedical research, climate change research, water resource management, materials engineering, neutron science and a range of other disciplines. ANSTO is a Federal Government agency with the mission to apply nuclear science for the benefit of all Australians. It operates Australia’s nuclear reactor, OPAL, for research and isotope production. Critical research carried out at ANSTO involves the neutron beam instruments attached to OPAL, run by ANSTO’s Bragg Institute, Australia’s leading neutron scattering research group. ANSTO operates particle accelerators to analyse the elemental composition and age of materials. ANSTO has two accelerators, ANTARES and STAR, both of which are used in ion beam analysis and accelerator mass spectrometry. Two new accelerators will be established, putting ANSTO at the forefront of this field worldwide. ANSTO is a founding partner in the national accelerator collaboration – Australian Collaboration for Accelerator Science (ACAS) – aimed at maintaining state-of-the-art facilities and a pool of accelerator experts. ANSTO is also one of the ten foundation investors in the Australian Synchrotron. As custodian of this world-class infrastructure, ANSTO attracts scientists from around the world to use the facilities. Approximately three hundred scientists use ANSTO’s neutron beam instuments each year, enabling productive collaborations, and keeping Australia at the forefront of scientific discovery. ANSTO researchers are engaged in international research through reciprocal arrangements with many organisations. Agreements for collaborations have recently been signed with the French Atomic Energy Commission, the Korean Atomic Energy Research Institute and CERN, home of the Large Hadron Collider in Switzerland.
  • Thumbnail Image
    Item
    ANSTO annual report 2010-2011
    (Australian Nuclear Science and Technology Organisation, 2011-10-05) Australian Nuclear Science and Technology Organisation
    ANSTO – the Australian Nuclear Science and Technology Organisation – is home to Australia’s nuclear expertise. ANSTO employs over 1,100 people in southwest Sydney, and supplies Australia with outstanding nuclear research, medicine and technology capabilities. The organisation provides policy advice to Government on all matters relating to nuclear science, technology and engineering. It supports Government in undertaking its international roles and obligations. It also undertakes research and pursues innovation in areas aligned with the national research priorities and those that have the potential to deliver key outcomes to support Australians and Australian industry. ANSTO strives to achieve key outcomes in publishing scientific research, securing intellectual property, training research students, developing software, providing engineering design and services, and consulting for industry. Innovation is critical to increasing Australia’s productivity and competitiveness. The Australian Government invested over $9 billion in science research and innovation in the 2010-2011 financial year and this investment is evident through the landmark science infrastructure Australian scientists can now access at ANSTO.
  • No Thumbnail Available
    Item
    ANSTO Research Highlight 2009-2009, Institute of Materials Engineering
    (Australian Nuclear Science and Technology Orgaisation, 2012-02) Australian Nuclear Science and Technology Orgaisation Institute of Materials Engineering
    This document contains a brief description of the research and operational highlights of Institute of Materials Engineering and a list of the published research outputs for the years 2007-2009 representing the first half of the period covered by the present review. The highlights are presented using a modified Frascati representation, which is presently used by ANSTO to classify its research.